Industry Partners and Profiles L - Z

The Intensive Care Society is extremely grateful to the following Industry Partners for their continued support:

LiDCO develops manufactures and markets medical devices primarily for Critical Care and Anaesthesia patients.

The LiDCOplus™ monitor, provides a range of hemodynamic parameters including beat to beat cardiac output (CO), oxygen delivery (DO2), stroke volume (SV), systemic vascular (SVR), blood pressure (BP) and dynamic preload parameters (PPV and SVV).The company also offers the LiDCOrapid™ Hemodynamic Monitor which is designed to facilitate fast and effective fluid management across the perioperative environment.
LiDCO’s validated technology has been shown to reduce complications by 40% and length of stay by an average of 12 days for high risk surgical patients (Pearse et al Critical Care). Our goal is to provide technology to help our customers manage the complex circulatory issues they encounter with the overriding aim of improving patient outcomes.

Profile to follow shortly.

Merck Serono Gastroenterology offers an extensive range of high quality, NPSA compliant enteral feeding devices, including the Corflo and Cortrak range. Cortrak uses electromagnetic technology to place nasogastric and nasojejunal tubes via the bedside.

Merck Serono recognise the importance of added value and as part of our commitment to our customers, we offer a wide range of services from training packages to patient advice materials as well as a dedicated account management team and medical information and patient support lines.

Orion is a European R&D pharmaceutical company focusing on developing new medicinal treatments. We aim to provide innovative products and first class service to patients, healthcare professionals and the community.

Orion UK have a dedicated specialist product team who will be committed to intensive care over the coming years.

Profile to follow shortly.

Picis provides a critical care information solution that takes full advantage of the advances in clinical documentation and workflow management, patient information generated from bedside devices, clinical decision support tools and remote access – resulting in improved critical care processes. In addition, Picis offers automatic notifications based on clinician-defined rules and business intelligence, providing actionable insight about patient stays within the critical care environment.

PULSION's main product developments are in the fields of anaesthesia, surgical and internal intensive care medicine, cardiology, as well as ophthalmology and tumour therapy. PULSION Medical Systems is superior in the development of practice-oriented monitoring systems and disposables that are used for diagnosis and treatment of the patient.

Sage's core belief is prevention—that evidence-based interventions will lead to improved outcomes. We are true innovators that turn ideas into clinically relevant products through research, support, and education. By promoting a return to the basics of nursing care, our advanced patient hygiene products and programmes help healthcare facilities improve clinical outcomes by reducing the risk of hospital-acquired infection and skin breakdown.

Smiths Medical is a leading global provider of medical devices for the hospital, emergency, home and specialist environments. Our products are used during critical and intensive care, surgery, post-operative care during recovery and in a series of high-end home infusion therapies. We offer some of the most respected and easily recognisable brands within our portfolio: CADD™ Deltec® BCI® wallace™ JELCO® GRASEBY™ LEVEL1® PORTEX® medfusion™ medex™ Pneupac™ & SurgiVet™

Headquartered near Seattle, SonoSite, Inc. (www.sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

SonoSite, Ltd., a wholly owned subsidiary of SonoSite, Inc. based in Hitchin, Hertfordshire, oversees a direct sales distribution network in the UK.

For nearly five decades, Spacelabs has been a pioneer and technology leader in patient monitoring with numerous firsts such as telemetry monitoring, modular non-invasive blood pressure and bedside device interfacing. Customer-driven innovation is a way of life at Spacelabs.

We are proud to introduce the XPREZZON - the future of connecting clinicians with patient information and it starts here from Spacelabs Healthcare. XPREZZON combines a legacy of proven performance with the ultimate fusion of form and function. Caregivers enjoy complete access to critical information; anywhere/anytime they have mobile access via a PC tablet application.

XPREZZON delivers innovative technology and design, to shape the new age of care for clinicians and patients alike. Come and visit Spacelabs Healthcare at the State of the Art Conference.

Thermo Fisher Scientific Clinical Diagnostics specialises in innovative biomarker products which facilitate earlier diagnosis of diseases and better control of therapy, thus enabling doctors to provide more efficient and economic patient care. Major fields of activity are diagnosis of Sepsis & Infection, Tumour Markers, Down’s syndrome screening and Thyroid diseases.

Thermo Fisher Scientific Clinical Diagnostics has recently entered the Cardiology and A&E markets with several new markers to help the clinician identify and differentiate several disease states.

• Copeptin for early rule out of Myocardial Infarction
• MRproANP for Heart Failure
• MRproADM as a prognostic marker for 30 day Mortality

• Procalcitonin is a biomarker which has been shown to be a useful additional tool in the diagnosis and prognosis of sepsis. The test is available in multiple formats making it more readily accessible to the clinician.

http://www.brahms.de
http://www.procalcitonin.com

Visensia, from OBS Medical, automatically analyses and interprets the combined patterns of a patient’s four or five vital signs – heart rate, temperature, blood press and blood oxygen regardless of whether they are collected continuously or periodically. The data is then fused to generate a predictive, numerical index (Visensia Index) representing the patient’s wellness throughout the hospital stay.